...
首页> 外文期刊>Food and Drug Law Journal >A voluntary disclosure program for FDA -- the time has come
【24h】

A voluntary disclosure program for FDA -- the time has come

机译:FDA的自愿披露计划-时机已到

获取原文
获取原文并翻译 | 示例
           

摘要

The Food and Drug Administration (FDA) should establish a voluntary disclosure program that would offer incentives to companies and others to voluntarily discover, disclose, and correct violations of the Federal Food, Drug, and Cosmetic Act (FDCA) and other FDA-enforced statutes. To be successful, the program must provide meaningful benefits to persons who otherwise would be liable for civil and criminal sanctions, but who opt to self-report the violation.
机译:美国食品药品监督管理局(FDA)应该建立自愿披露计划,以鼓励企业和其他公司自愿发现,披露和纠正违反《联邦食品,药物和化妆品法》(FDCA)和其他FDA强制执行的法规的情况。 。为了取得成功,该计划必须为那些本应承担民事和刑事制裁但选择自行举报侵权行为的人提供有意义的利益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号